Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer

Clinical trial NCT00461344 · TERMINATED

Trial details

NCT number: NCT00461344
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Ductal Carcinoma

Start date: 2004-07-01
Primary completion: 2005-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.